Skip to content
Lower risk Drug recall · FDA · Published January 27, 2020

Teva Methylphenidate Extended-Release Recall: Missing Desiccant Risk

Teva recalls 27mg Methylphenidate extended-release tablets due to possible missing desiccant, which may cause moisture damage. This is a controlled substance prescription-only product.

🇺🇸 FDA recall #D-0837-2020DrugTeva Pharmaceuticals ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA400 Interpace Pkwy · Parsippany, NJ 07054-1120
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva Pharmaceuticals is recalling 27mg Methylphenidate hydrochloride Extended-Release tablets (100-count) because the product bottles might not contain the desiccant. This could lead to moisture damage affecting the medication's stability. Read more at govinfonow.com/recall/37397-teva-methylphenidate-extended-release-recall-missing-desiccant-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37397-teva-methylphenidate-extended-release-recall-missing-desiccant-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0837-2020

Cite this page

“Teva Methylphenidate Extended-Release Recall: Missing Desiccant Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37397-teva-methylphenidate-extended-release-recall-missing-desiccant-risk. Based on FDA recall #D-0837-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0837-2020%22&limit=1).

Why it’s dangerous

The product bottles may be missing the desiccant, which helps keep the medication dry. Without it, moisture could damage the tablets, potentially affecting their effectiveness or safety.

Who’s affected

Prescription patients who have the 27mg Methylphenidate extended-release tablets (NDC 62037-734-01) from Teva Pharmaceuticals. Those with the product may be at risk if the desiccant is missing.

How to tell if you have this one

Check for the product name 'Methylphenidate hydrochloride Extended-Release ablets USP (CII)', 27 mg, 100-count bottle, prescription-only from Teva Pharmaceuticals. The lot number is 1332799A with an expiration date of November 2020.

  • Brand
    Teva Pharmaceuticals
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    USA Nationwide
  • NDC
    62037-725-01, 62037-734-01, 62037-726-01, 62037-727-01
Recall numberProduct, codes & lotsQuantity
D-0836-2020Methylphenidate hydrochloride Extended-Release ablets USP (CII), 18 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-725-01; Lot #: 1332796 A, Exp 11/2020—
D-0837-2020Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01; Lot # 1332799A, Exp 11/202017,436 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the product name, strength, and lot number to confirm if it matches the recalled items.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Jan 27, 202012. FDA classified it Class II: Feb 10, 202023. Published in FDA’s Enforcement Report: Feb 19, 202034. FDA terminated the recall: Nov 3, 202042020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to possible missing desiccant, which could affect the medication's stability. The product may still be safe if the desiccant is present, but it's recommended to check with the manufacturer.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0837-2020 (January 27, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0837-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA